President Trump has promoted a few different drugs as effective remedies against the novel coronavirus in recent days, but demand for one of them has become so overwhelming that its manufacturer has temporarily shut down its emergency access program to build a broader one, The New York Times reports.
Gilead, which produces remdesivir, a drug that's being studied in large-scale clinical trials across the globe and is currently administered in certain coronavirus cases, said it can no longer grant compassionate use requests because it can't keep up with the number coming in. The company said its emergency access program was limited and never intended for a pandemic, but now that the world is facing one, Gilead intends to set up a broader access program to help more people. "This approach will both accelerate access to remdesivir for severely ill patients and enable the collection of data from all participating patients," the company said in a statement.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Create an account with the same email registered to your subscription to unlock access.
-
'Making a police state out of the liberal university'Instant Opinion Opinion, comment and editorials of the day
-
8 looming climate tipping points that imperil our planetThe Explainer New reports detail the thresholds we may be close to crossing
-
Try 6 free issues of The Week JuniorSpark your child's curiosity with The Week Junior - the award-winning current affairs magazine for 8-14s.
-
Texas dairy worker gets bird flu from infected cowSpeed Read The virus has been spreading among cattle in Texas, Kansas, Michigan and New Mexico
-
Dengue hits the Americas hard and earlySpeed Read Puerto Rico has declared an epidemic as dengue cases surge
-
Covid four years on: have we got over the pandemic?Today's Big Question Brits suffering from both lockdown nostalgia and collective trauma that refuses to go away
-
US bans final type of asbestosSpeed Read Exposure to asbestos causes about 40,000 deaths in the U.S. each year
-
The hollow classroomOpinion Remote school let kids down. It will take much more than extra tutoring for kids to recover.
-
Excess screen time is making children only see what is in front of themUnder the radar The future is looking blurry. And very nearsighted.
-
Covid-19: what to know about UK's new Juno and Pirola variantsin depth Rapidly spreading new JN.1 strain is 'yet another reminder that the pandemic is far from over'
-
Long-term respiratory illness is here to stayThe Explainer Covid is not the only disease with a long version
